Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 10173039

Testicular implants.

Y Lakshmanan·S G Docimo
View original source ↗Export metadata ↓

Abstract

Testicular implants have been in use for more than 50 years with an excellent record of safety and efficacy. The controversy concerning the use of silicone prosthetics in breast implants also affected testicular implants. There is no conclusive evidence associating connective tissue disorders, autoimmunity, or malignancy with silicone implants. Studies show silicone leakage from these implants, but long-term follow-up is required to identify the significance of this finding. Saline-filled silastic shell testicular prostheses will be implanted as part of an ongoing study to monitor various safety parameters, as required by the Food and Drug Administration.

Explore related subjects

Biocompatible MaterialsDimethylpolysiloxanesHumansMaleProstheses and ImplantsSiliconesTestisJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Y Lakshmanan, S G Docimo. 1997. Testicular implants.. https://pubmed.ncbi.nlm.nih.gov/10173039/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

In situ complement activation by polyethylene wear debris.

A frequent long-term complication of total joint arthroplasty is aseptic loosening, the end result of wear debris accumulation, synovitis, and osteolysis about the implant-bone or cement-bone interface. Complement, an effector system in plasma, synovial fluid, and tissue, has powerful chemotactic, inflammatory, and osteoclast-activating potentials. This study explored the complement-activating ability of polyethylene, a material used in joint implants. In vitro hemolytic assays using sheep red blood cells (E(sh)), human serum, and particulate polyethylene suggested alternative pathway complement activation, as well as polyethylene adsorption of activated complement components. These results were confirmed by enzyme-linked immunosorbent assay (ELISA) quantification of activated complement factors Bb and C3b. In situ double antibody immunoperoxidase staining for factors Bb, C3a, iC3b, and SC5-9 in synovial tissue from revision hip specimens showed localized alternative pathway activation and component adsorption. These results introduce a likely role for complement activation in particle-mediated recruitment, proliferation, and activation of macrophages during early events in osteolysis and implant loosening.

Biocompatible Materials↗
PubMed2001

Biodegradable dextran-polylactide hydrogel network and its controlled release of albumin.

The objective of this paper was to study the release of bovine serum albumin (BSA) from a series of biodegradable hydrogels having a wide range of hydrophilicity to hydrophobicity, swelling, and biodegradation properties. BSA was incorporated into a series of biodegradable hydrogels made from a dextran derivative of allyl isocyanate (dex-AI, as the hydrophilic constituent) and poly(DL-lactic acid) diacrylate macromer (PDLLAM, as the hydrophobic constituent). The release kinetics of BSA from these dex-AI/PDLLAM hydrogels was studied. Laser confocal scanning microscopy was used to investigate the morphological change of the hydrogels, as well as BSA distribution in the hydrogels, as a function of dex-AI to PDLLAM composition ratio and incubation time. We found that the incorporation of PDLLAM into dex-AI reduced the initial burst release of BSA due to its more homogeneous distribution in the hydrogels. As the PDLLAM component increased, the rate of formation of a loose three-dimensional (3D) network structure increased; consequently, the sustained rate and extent of BSA release increased. Both release index and diffusion coefficient (from release kinetics data) increased as the PDLLAM component increased in the hydrogels. The data suggest that the release of BSA was controlled by both diffusion of BSA through swelling of the hydrophilic phase during an early stage, and degradation of the hydrophobic phase during a late stage, and also that the magnitude of diffusion versus degradation controlled release is dependent on composition ratio and immersion time.

Biocompatible Materials↗
PubMed2001

Preparation and mechanical properties of polylactic acid composites containing hydroxyapatite fibers.

Ceramic-polymer composite biomaterials were prepared by hot-pressing a mixture consisting of poly-L-lactic acid (PLA) and hydroxyapatite fibers (HAF) with dimensions of 40-150 microm length and 2-10 microm diameter, which were converted from beta-Ca(PO3)2 fibers. After PLA dissolved with methylene chloride was mixed with the fibers, the mixture was dried completely and subsequently hot-pressed uniaxially under a pressure of 40 MPa at 180 degrees C, resulting in the fabrication of the PLA/HAF composite. The modulus of elasticity was improved effectively even by introducing a small amount of HAF; almost no degradation in the bending strength was observed and the modulus of elasticity showed high values of 5-10 GPa when the fibers of 20-60 wt% were introduced. With increasing HAF content, the maximum strain decreases and the specimen is apt to show a brittle fracture; this result implies that HAF in the composites can share the applied load efficiently due to the formation of a bond between HAF and PLA.

Biocompatible Materials↗